Production (Stage)
Select Medical Holdings Corporation
SEM
$14.39
-$0.10-0.69%
NYSE
03/31/2025 | 12/31/2024 | ||||
---|---|---|---|---|---|
Revenue | 3.09% | -25.47% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 3.09% | -25.47% | |||
Cost of Revenue | -6.45% | -17.32% | |||
Gross Profit | 84.64% | -59.57% | |||
SG&A Expenses | 32.50% | -46.55% | |||
Depreciation & Amortization | -4.07% | -27.64% | |||
Other Operating Expenses | -- | 91.86% | |||
Total Operating Expenses | -3.95% | -20.28% | |||
Operating Income | 434.56% | -85.06% | |||
Income Before Tax | 743.68% | -113.86% | |||
Income Tax Expenses | 578.11% | -116.74% | |||
Earnings from Continuing Operations | 814.73% | -112.91% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | 8.86% | 21.98% | |||
Net Income | 453.15% | -128.85% | |||
EBIT | 434.56% | -85.06% | |||
EBITDA | 120.78% | -65.06% | |||
EPS Basic | 432.83% | -130.83% | |||
Normalized Basic EPS | 333.73% | -136.41% | |||
EPS Diluted | 432.83% | -130.83% | |||
Normalized Diluted EPS | 333.73% | -136.41% | |||
Average Basic Shares Outstanding | 0.22% | 0.97% | |||
Average Diluted Shares Outstanding | 0.22% | 0.97% | |||
Dividend Per Share | 0.00% | -50.00% | |||
Payout Ratio | 1.14% | -4.45% |